IMPACT Study - Payors

Payors comprised 50 health policy managers and decision-makers, 10 from each of the 5 participating European countries. The group consisted of individuals who were considered to be decision-makers for placing Alzheimer's disease therapies on formulary lists or who were involved in developing protocols/guidelines for treating Alzheimer's disease. Participants included those with the following job titles: pharmaceutical or prescribing advisor, finance director, interface pharmacist or interface prescribing advisor, influencer, decision-maker or commissioning manager.

Instructions | Physician results | General public results | Payor results | IMPACT study home